PSA and obesity among men with localized prostate cancer: results of the ANDROCAN study.
Matthias E MeunierYann NeuzilletJean-François DreyfusMarc SchneiderMorgan RouprêtXavier CathelineauJean-Pierre RaynaudThierry LebretHenry BottoPublished in: World journal of urology (2021)
In this prospective study of patients with localized prostate cancer, higher BMI was associated with higher PSA mass but not with higher PSA concentration. Screening obese patients with a specific PSA method does not appear to be critical.